Edition:
United Kingdom

People: 3D Systems Corp (DDD.N)

DDD.N on New York Stock Exchange

10.89USD
18 Apr 2019
Change (% chg)

$-0.11 (-1.00%)
Prev Close
$11.00
Open
$10.99
Day's High
$11.07
Day's Low
$10.85
Volume
225,929
Avg. Vol
416,873
52-wk High
$21.76
52-wk Low
$9.00

Curran, William 

Mr. William Edward Curran is an Independent Director of 3D Systems Corporation. Currently retired, Mr. Curran has served as a director of Profound Medical, a public company developing a treatment for prostate cancer using ablative ultrasound and guided by magnetic resonance imaging and thermometry, since 2012. Previously, Mr. Curran served as non-executive Chairman and Director of Resonant Medical, an early-stage privately owned company specializing in three-dimensional ultrasound image-guided adaptive radio therapy products, until May 2010 at which time Resonant was sold to Elekta A.B. He also served until May 2009 as a director of Ventracor, a global medical device company which produced an implantable blood pump, at which time the directors brought in an administrator under Australian law. For more than five years prior to 2004, he held diverse functional and senior management positions with Philips Electronics and Philips Medical Systems. His experience at Philips Medical Systems, a medical device manufacturer, included positions as Chief Operating Officer and Chief Financial Officer, and while at Philips Electronics North America he served as President and Chief Executive Officer as well as Chief Financial Officer.

Basic Compensation

Total Annual Compensation, USD 119,250
Restricted Stock Award, USD 99,997
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 219,247

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Charles McClure

171,123

Vyomesh Joshi

1,933,110

John McMullen

807,968

Charles Hull

596,011

Kevin McAlea

697,104

Andrew Johnson

612,993
As Of  31 Dec 2017